QPharma is one of the few CDMOs specializing in controlled release systems for highly potent drugs, offering end-to-end services. The company's expertise encompasses the development of new products across various stages of development and the manufacturing of commercial products. QPharma specializes in Polymer-based sustained release dosage forms such as vaginal rings and implants, prefilled syringes and other High Potent drug products.
Looking for a particular QPharma AB employee's phone or email?
The QPharma AB annual revenue was $22 million in 2026.
Wouter de Graaff is the Chief Scientific Officer of QPharma AB.
200 people are employed at QPharma AB.
QPharma AB is based in Malmoe, Skane.
The NAICS codes for QPharma AB are [32541, 325, 3254, 32].
The SIC codes for QPharma AB are [28, 283].